For: | Boyalı O, Kabatas S, Civelek E, Ozdemir O, Bahar-Ozdemir Y, Kaplan N, Savrunlu EC, Karaöz E. Allogeneic mesenchymal stem cells may be a viable treatment modality in cerebral palsy. World J Clin Cases 2024; 12(9): 1585-1596 [PMID: 38576742 DOI: 10.12998/wjcc.v12.i9.1585] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v12/i9/1585.htm |
Number | Citing Articles |
1 |
Serdar Kabatas, Erdinç Civelek, Eyüp Can Savrunlu, Umut Karaaslan, Özlem Yıldız, Erdal Karaöz. Advances in the treatment of autism spectrum disorder: Wharton jelly mesenchymal stem cell transplantation. World Journal of Methodology 2025; 15(1): 95857 doi: 10.5662/wjm.v15.i1.95857
Abstract(493) |
Core Tip(621) |
Full Article(HTML)(3650)
|
Full Article with Cover (PDF)-9286K(84)
|
Audio-1048K(25)
|
Video (1-1)(18)
|
Peer-Review Report-193K(69)
|
Answering Reviewers-177K(54)
|
Full Article (PDF)-8879K(176)
|
Full Article (XML)-66K(57)
|
Times Cited (0)
|
Total Visits (6756)
|
Open
|
2 |
Madison C. B. Paton, Alexandra R. Griffin, Remy Blatch-Williams, Annabel Webb, Frances Verter, Pedro S. Couto, Alexey Bersenev, Russell C. Dale, Himanshu Popat, Iona Novak, Megan Finch-Edmondson. Clinical Evidence of Mesenchymal Stromal Cells for Cerebral Palsy: Scoping Review with Meta-Analysis of Efficacy in Gross Motor Outcomes. Cells 2025; 14(10): 700 doi: 10.3390/cells14100700
|
3 |
Ana-Marie Rojas. Long-term impact of early identification of cerebral palsy. Current Opinion in Pediatrics 2025; 37(2): 205 doi: 10.1097/MOP.0000000000001439
|